ناشر تخصصی کنفرانس های ایران

لطفا کمی صبر نمایید

Publisher of Iranian Journals and Conference Proceedings

Please waite ..
Publisher of Iranian Journals and Conference Proceedings
Login |Register |Help |عضویت کتابخانه ها
Paper
Title

Oral Supplementation of Camelina Oil extract in Dry Eye Patients.

Year: 1398
COI: ACSOMED29_063
Language: EnglishView: 341
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

Authors

Hossein Aghamollaei, - Vision health Research Center, Semnan University of medical sciences
Mahdieh Rihani, - Vision health Research Center, Semnan University of medical sciences
Ali Barzegar, - Vision health Research Center, Semnan University of medical sciences
Khosrow Jadidi - Vision health Research Center, Semnan University of medical sciences
Danial Kahrizi - Vision health Research Center, Semnan University of medical sciences

Abstract:

Purpose: Camelina sativa is an oil seeded plant. The major component in the Camelina oil composition is the omega-3 fatty acid .The aim of this study was evaluation of the safety and efficacy of Camelina oil extract capsules in patients suffering from dry eye symptoms. Methods: A randomized, triple-blind, interventional, placebo-controlled study was done. Fifty three patients were randomized in two groups to receive either two capsules containing 500mg of Camelina oil extract or placebo daily for 3 months. Uncorrected distance visual acuity (UCVA), tear film break-up time (TBUT), Schirmer’s test, tear meniscus height (TMH) and Ocular Surface Disease Index (OSDI) score were recorded at baseline and 3 months after intervention. Results: After three months, in Camelina group, the mean TBUT and TMH was significantly improved (P-Value <0.05). Also the OSDI score was significantly reduced from 30.25 to 25.58. (P-Value < 0.05). In Placebo group, the OSDI was significantly reduced from 34.65 to 20. Comparison between these groups showed that UCVA (p=0.040), TBUT (p=0.027) and TMH(p=0.034) were significantly increased in Camelina than placebo group. There was not any serious complication in patients enrolled in this study. Conclusion: Consumption of 1000 mg of Camelina oil extract is safe in patient with dry eye. This supplement can reduce the dry eye syndrome. For more validation, a multicentral clinical study with large sample size is proposed.

Paper COI Code

This Paper COI Code is ACSOMED29_063. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:

https://civilica.com/doc/969144/

How to Cite to This Paper:

If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:
Aghamollaei,, Hossein and Rihani,, Mahdieh and Barzegar,, Ali and Jadidi, Khosrow and Kahrizi, Danial,1398,Oral Supplementation of Camelina Oil extract in Dry Eye Patients.,xxix annual congress of the iranian society of ophthalmology,Mashhad,https://civilica.com/doc/969144

Research Info Management

Certificate | Report | من نویسنده این مقاله هستم

اطلاعات استنادی این Paper را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.

Scientometrics

The specifications of the publisher center of this Paper are as follows:
Type of center: علوم پزشکی
Paper count: 893
In the scientometrics section of CIVILICA, you can see the scientific ranking of the Iranian academic and research centers based on the statistics of indexed articles.

Share this page

More information about COI

COI stands for "CIVILICA Object Identifier". COI is the unique code assigned to articles of Iranian conferences and journals when indexing on the CIVILICA citation database.

The COI is the national code of documents indexed in CIVILICA and is a unique and permanent code. it can always be cited and tracked and assumed as registration confirmation ID.

Support